E

Elucid

AI-powered plaque analysis for cardiovascular imaging

Machine Learning PhD Intern

Natural Language Processing & LLMsPosted on Nov 6
Internship · Spring 2027Boston, MA, USA$60 - $65 /hr

About the Job

Requirements

  • Be a PhD student in Machine Learning, Computer Science, Electrical Engineering, or a related field, with a focus on foundation models and an interest in healthcare technology.
  • Have hands-on experience with Python and PyTorch and tools such as PEFT/LoRA, Hugging Face, or LangGraph (or similar) for model development, fine-tuning, and agentic workflows.
  • Have experience with image data and complex datasets, including multimodal, richly labeled, or substantially preprocessed data.

Responsibilities

  • Design, build, and evaluate large language model and vision-language model agents and workflows.
  • Create proofs of concept for real applications of foundation models.

Desired Qualifications

  • AWS experience with EC2, S3, or SageMaker.
  • Biomedical or volumetric data experience, such as DICOMs; cardiovascular imaging experience is especially valuable.
  • Substantial publications in the domain of large language models or vision-language models.
  • Experience with human-in-the-loop training, reinforcement learning from human feedback, or tools such as nnInteractive.
  • Experience working in an FDA-regulated environment.

About the Company

Elucid

AI-powered plaque analysis for cardiovascular imaging

Elucid Bioimaging provides an AI-powered SaaS platform that helps clinicians diagnose and manage cardiovascular disease by analyzing coronary CT angiography images to quantify plaque and model the coronary arteries. PlaqueIQ uses machine learning trained on paired CCTA data and histology to identify plaque types, create a 3D artery model, and move toward non-invasive FFR measurements (FFRCT). The product stands out by using histology-grounded AI with FDA 510(k) clearance and CE marking, offering more detailed plaque characterization than many competitors. The company aims to expand sales in North America and Europe to enable precision cardiology and preventive treatment, with the goal of reducing heart attacks and strokes.

Company size
51-200
Company stage
Series D
Total funding
$183.3M
Headquarters
Boston, MA
Founded
2013

Recently Posted Jobs

Explore more opportunities at Elucid

See more jobs